動物生長促進劑及性能增強劑市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球動物生長促進劑和性能增強劑市場價值為 163 億美元，預計到 2034 年將以 6.3% 的複合年成長率成長，達到 298 億美元，這得益於發展中國家強勁的發展勢頭。這些地區的快速城市化、可支配收入的增加以及不斷變化的飲食偏好正在推動動物性蛋白質消費量的增加。隨著全球糧食系統面臨提高畜牧業生產力、效率和永續性的越來越大的壓力，這個市場變得越來越重要。隨著全球人口的成長和對高品質蛋白質需求的不斷成長，對有效動物生長促進劑的需求從未如此強烈。商業畜牧業生產的集約化，尤其是在亞太地區和拉丁美洲，凸顯了對可擴展、經濟高效的解決方案的需求。此外，飼料科學的進步、動物福利意識的提高以及更嚴格的監管框架正在重塑產品開發策略。消費者和生產者都在尋求多功能解決方案，不僅可以提高生長率，還可以改善免疫功能、營養吸收和整體動物福祉，推動抗生素和非抗生素產品領域的創新。

在亞太地區，大規模商業畜牧養殖正在迅速擴張，以滿足日益成長的國內需求，這對區域市場動態產生了重大影響。中國、印度和越南等國家的蛋白質消費量激增，推動了對先進飼料技術和性能增強型產品的投資。隨著消費者期望的不斷變化以及政府對食品安全與食品安全的重視，市場參與者紛紛推出綜合飼料添加劑，以在不損害動物健康和合規性的前提下提高生產效率。

最強勁的成長催化劑之一仍然是全球對動物性蛋白質日益成長的需求，這促使食品生產商提高營運效率。因此，畜牧養殖戶擴大將促生長添加劑納入其飼料策略。如今的現代農業實踐優先考慮高產量和成本效益，這為能夠改善增重、增強免疫力和維持畜群健康的增效劑創造了巨大的市場，尤其是在高產量、集約化養殖系統中。這些添加劑不再被視為可有可無的工具，而是在控制成本的同時實現產量最大化的必要投入。

2024年，抗生素和非抗生素產品市場規模達48億美元，預計2025年至2034年的複合年成長率為6%。長期以來，抗生素一直被用於促進增重和控制疾病風險，尤其是在工業化畜牧業。然而，全球對抗生素抗藥性日益成長的擔憂，加上監管準則的日益嚴格，正在加速向非抗生素替代品的轉變。產業領導者正在投資益生菌、益生元、酵素和植物性物質等先進解決方案，以在符合全球食品安全標準的同時，提供類似的性能優勢。消費者意識的增強以及對動物產品供應鏈透明度的需求也推動了這一轉變。

2024年，家禽業佔據動物生長促進劑和性能增強劑市場的最大佔有率，產值達74億美元，預計到2034年將以6.7%的複合年成長率成長，佔據整個市場的45.4%。受全球對雞肉和雞蛋等價格實惠的瘦肉蛋白的強勁需求推動，該領域持續強勁擴張。家禽生產者高度依賴飼料增效劑來降低死亡率並提高產量，尤其是在全球生產週期較短、文化消費障礙相對較低的情況下。這些因素使家禽養殖成為飼料性能技術創新的重點領域。

美國動物生長促進劑和性能增強劑市場在2024年創收37億美元，預計2034年將以6.1%的複合年成長率成長。國內對肉類和乳製品的旺盛需求，正鼓勵企業加大對飼料效率解決方案的投資。美國生產商也在適應不斷變化的藥物和非藥物飼料添加劑監管法規，這促使其轉向更永續、更注重合規的做法。隨著對動物福利和消費者安全的重視，美國市場正成為非抗生素生長解決方案研發和產品開發的中心。

全球動物生長促進劑和性能增強劑市場的主要公司包括Bioniche Animal Health、帝斯曼、勃林格殷格翰、拜耳動物保健、默克動物保健、嘉吉公司、碩騰公司、百奧明控股有限公司、保寶動物保健和禮來動物保健公司。這些市場領導者正在加大研發投入，以開發安全、有效且符合法規要求的替代方案。他們的策略包括透過植物性和益生菌成分實現產品組合多元化、與飼料製造商建立合作夥伴關係，以及拓展新興市場的業務，以利用區域成長潛力。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
  • 影響價值鏈的因素
  • 利潤率分析
  • 中斷
  • 未來展望
  • 製造商
  • 經銷商
• 川普政府關稅
  • 對貿易的影響
    • 貿易量中斷
    • 報復措施
  • 對產業的影響
    • 供應方影響（原料）
      • 主要材料價格波動
      • 供應鏈重組
      • 生產成本影響
  • 需求面影響（銷售價格）
    • 價格傳導至終端市場
    • 市佔率動態
    • 消費者反應模式
  • 受影響的主要公司
  • 策略產業反應
    • 供應鏈重組
    • 定價和產品策略
    • 政策參與
  • 展望與未來考慮
• 貿易統計（HS編碼）
  • 2021-2024年主要出口國
  • 2021-2024年主要進口國

註：以上貿易統計僅針對重點國家。

• 供應商格局
• 利潤率分析
• 重要新聞和舉措
• 監管格局
• 衝擊力
  • 成長動力
    • 全球對動物性蛋白質的需求不斷成長
    • 畜牧養殖集約化
    • 動物營養和飼料添加劑的進展
    • 新興市場商業畜牧業生產的擴張
  • 產業陷阱與挑戰
    • 對抗生素類生長促進劑的監管限制
    • 消費者對有機和無抗生素肉的偏好日益成長
• 成長潛力分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第5章：市場估計與預測：依產品，2021 - 2034 年

• 主要趨勢
• 抗生素和非抗生素
• 益生菌和益生元
• 有機酸
• 植物源性
• 飼料酵素
• 荷爾蒙
• 其他

第6章：市場估計與預測：依動物類型，2021 - 2034 年

• 主要趨勢
• 家禽
• 豬
• 家畜
• 水生動物
• 其他動物

第7章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• MEA
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第8章：公司簡介

• Bayer Animal Health
• Biomin Holding GmbH
• Bioniche Animal Health
• Boehringer Ingelheim
• Bupo Animal Health
• Cargill Inc.
• DSM
• Elanco Animal Health Incorporated
• Merck Animal Health
• Zoetis Inc.

The Global Animal Growth Promoters and Performance Enhancers Market was valued at USD 16.3 billion in 2024 and is estimated to grow at a CAGR of 6.3% to reach USD 29.8 billion by 2034, driven by strong momentum across developing regions where rapid urbanization, rising disposable incomes, and evolving dietary preferences are fueling higher consumption of animal-based proteins. This market is becoming increasingly vital as global food systems face mounting pressure to improve livestock productivity, efficiency, and sustainability. With an expanding global population and a rising appetite for high-quality protein, the demand for effective animal growth promoters has never been more pronounced. The intensification of commercial livestock production, particularly in Asia Pacific and Latin America, underscores the need for scalable, cost-effective solutions. Furthermore, advances in feed science, increased awareness around animal welfare, and stricter regulatory frameworks are reshaping product development strategies. Consumers and producers alike are seeking multifunctional solutions that not only enhance growth rates but also contribute to improved immune function, nutrient absorption, and overall animal well-being-driving innovation in both antibiotic and non-antibiotic product segments.

In Asia Pacific, large-scale commercial livestock operations are rapidly expanding to meet growing domestic demand, significantly impacting regional market dynamics. Countries like China, India, and Vietnam are witnessing a surge in protein consumption, propelling investment into advanced feed technologies and performance-enhancing products. With evolving consumer expectations and governmental emphasis on food security and safety, market players are responding with integrated feed additives that deliver productivity gains without compromising health or regulatory compliance.

One of the strongest growth catalysts remains the rising global demand for animal-derived proteins, which is pushing food producers to improve operational efficiency. As a result, livestock farmers are increasingly incorporating growth-promoting additives into their feed strategies. Today's modern farming practices prioritize high yield and cost-effectiveness, creating a significant market for performance enhancers that improve weight gain, fortify immune response, and maintain herd health-especially in high-volume, intensive farming systems. These additives are no longer seen as optional tools but as essential inputs to maximize output while controlling overhead.

In 2024, the antibiotic and non-antibiotic product segment accounted for USD 4.8 billion, with forecasts predicting a CAGR of 6% from 2025 to 2034. Antibiotics have long been utilized to promote weight gain and manage disease risks, particularly in industrial livestock operations. However, the increasing global concern over antimicrobial resistance, coupled with stricter regulatory guidelines, is accelerating a shift toward non-antibiotic alternatives. Industry leaders are investing in advanced solutions such as probiotics, prebiotics, enzymes, and phytogenics to deliver similar performance benefits while aligning with global food safety standards. This transition is also supported by heightened consumer awareness and a demand for transparency in animal product supply chains.

The poultry sector held the largest share of the animal growth promoters and performance enhancers market in 2024, generating USD 7.4 billion and projected to grow at a CAGR of 6.7% through 2034, capturing 45.4% of the total market. Driven by strong global demand for affordable, lean protein like chicken meat and eggs, this segment continues to experience robust expansion. Poultry producers rely heavily on feed efficiency enhancers to reduce mortality and improve output, especially given the shorter production cycles and relatively low cultural consumption barriers worldwide. These factors make poultry farming a key focus area for innovation in feed performance technology.

The United States Animal Growth Promoters and Performance Enhancers Market generated USD 3.7 billion in 2024 and is expected to grow at a CAGR of 6.1% through 2034. A high domestic demand for meat and dairy products is encouraging greater investment in feed efficiency solutions. U.S. producers are also adapting to evolving regulations that govern both medicated and non-medicated feed additives, prompting a shift toward more sustainable, compliance-focused practices. With an emphasis on animal welfare and consumer safety, the U.S. market is emerging as a hub for R&D and product development in non-antibiotic growth solutions.

Major companies operating in the global animal growth promoters and performance enhancers market include Bioniche Animal Health, DSM, Boehringer Ingelheim, Bayer Animal Health, Merck Animal Health, Cargill Inc., Zoetis Inc., Biomin Holding GmbH, Bupo Animal Health, and Elanco Animal Health Incorporated. These market leaders are intensifying R&D investments to develop safe, effective, and regulation-compliant alternatives. Their strategies include diversifying portfolios with plant-based and probiotic ingredients, forging partnerships with feed manufacturers, and expanding operations in emerging markets to capitalize on regional growth potential.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021 - 2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Trump administration tariffs
  • 3.2.1 Impact on trade
    • 3.2.1.1 Trade volume disruptions
    • 3.2.1.2 Retaliatory measures
  • 3.2.2 Impact on the industry
    • 3.2.2.1 Supply-Side impact (Raw Materials)
      • 3.2.2.1.1 Price volatility in key materials
      • 3.2.2.1.2 Supply chain restructuring
      • 3.2.2.1.3 Production cost implications
  • 3.2.3 Demand-Side impact (Selling Price)
    • 3.2.3.1 Price transmission to end markets
    • 3.2.3.2 Market share dynamics
    • 3.2.3.3 Consumer response patterns
  • 3.2.4 Key companies impacted
  • 3.2.5 Strategic industry responses
    • 3.2.5.1 Supply chain reconfiguration
    • 3.2.5.2 Pricing and product strategies
    • 3.2.5.3 Policy engagement
  • 3.2.6 Outlook and future considerations
• 3.3 Trade statistics (HS Code)
  • 3.3.1 Major exporting countries, 2021-2024 (Kilo Tons)
  • 3.3.2 Major importing countries, 2021-2024 (Kilo Tons)

Note: the above trade statistics will be provided for key countries only.

• 3.4 Supplier landscape
• 3.5 Profit margin analysis
• 3.6 Key news & initiatives
• 3.7 Regulatory landscape
• 3.8 Impact forces
  • 3.8.1 Growth drivers
    • 3.8.1.1 Rising global demand for animal-based protein
    • 3.8.1.2 Intensification of livestock farming practices
    • 3.8.1.3 Advancements in animal nutrition and feed additives
    • 3.8.1.4 Expansion of commercial livestock production in emerging markets
  • 3.8.2 Industry pitfalls & challenges
    • 3.8.2.1 Regulatory restrictions on antibiotic-based growth promoters
    • 3.8.2.2 Growing consumer preference for organic and antibiotic-free meat
• 3.9 Growth potential analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021 - 2034 (USD Billion) (Kilo Tons)

• 5.1 Key trends
• 5.2 Antibiotic & non-antibiotic
• 5.3 Probiotic and prebiotic
• 5.4 Organic acid
• 5.5 Phytogenic
• 5.6 Feed enzyme
• 5.7 Hormonal
• 5.8 Others

Chapter 6 Market Estimates & Forecast, By Animal Type, 2021 - 2034 (USD Billion) (Kilo Tons)

• 6.1 Key trends
• 6.2 Poultry
• 6.3 Swine
• 6.4 Livestock
• 6.5 Aquatic animals
• 6.6 Other animals

Chapter 7 Market Estimates & Forecast, By Region, 2021 - 2034 (USD Billion) (Kilo Tons)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 UK
  • 7.3.2 Germany
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 South Korea
  • 7.4.5 Australia
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 MEA
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Bayer Animal Health
• 8.2 Biomin Holding GmbH
• 8.3 Bioniche Animal Health
• 8.4 Boehringer Ingelheim
• 8.5 Bupo Animal Health
• 8.6 Cargill Inc.
• 8.7 DSM
• 8.8 Elanco Animal Health Incorporated
• 8.9 Merck Animal Health
• 8.10 Zoetis Inc.